Mersana Therapeutics, Inc. Total Liabilities
Mersana Therapeutics, Inc. had Total Liabilities of $122.22 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-11-14
- 2025-09-30: Liabilities $122.22M.
- 2025-06-30: Liabilities $137.72M.
- 2025-03-31: Liabilities $143.34M.
- 2024-12-31: Liabilities $154.17M.
| Period end | Liabilities |
|---|---|
| 2025-09-30 | $122.22M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $137.72M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $143.34M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $154.17M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $168.48M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $170.70M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $170.39M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $189.16M 10-K · filed 2025-03-03 |
| 2023-09-30 | $210.71M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $221.20M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $231.90M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $242.28M 10-K · filed 2024-02-28 |
| 2022-09-30 | $224.62M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $118.32M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $117.74M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $84.37M 10-K · filed 2023-02-28 |
| 2021-09-30 | $62.04M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $58.17M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $49.97M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $45.31M 10-K · filed 2022-02-28 |
| 2020-09-30 | $36.82M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $36.95M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $32.77M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $29.22M 10-K · filed 2021-02-26 |
| 2019-09-30 | $28.61M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $30.87M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $25.32M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $69.71M 10-K · filed 2020-02-28 |
| 2018-09-30 | $64.52M 10-Q · filed 2018-11-13 |
| 2017-12-31 | $60.72M 10-K · filed 2019-03-08 |